175 related articles for article (PubMed ID: 21193967)
1. Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience.
Díaz R; Munárriz B; Santaballa A; Palomar L; Montalar J
Med Oncol; 2012 Mar; 29(1):16-24. PubMed ID: 21193967
[TBL] [Abstract][Full Text] [Related]
2. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in hormone-receptor status and survival outcomes among women with synchronous and metachronous bilateral breast cancers.
Baretta Z; Olopade OI; Huo D
Breast; 2015 Apr; 24(2):131-6. PubMed ID: 25534718
[TBL] [Abstract][Full Text] [Related]
4. Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer.
Ding S; Sun X; Lu S; Wang Z; Chen X; Shen K
Breast; 2021 Jun; 57():71-79. PubMed ID: 33774461
[TBL] [Abstract][Full Text] [Related]
5. Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up.
Eliyatkin N; Zengel B; Yagci A; Comut E; Postaci H; Uslu A; Aktas S
Asian Pac J Cancer Prev; 2015; 16(12):4921-6. PubMed ID: 26163616
[TBL] [Abstract][Full Text] [Related]
6. The prognosis of synchronous and metachronous bilateral breast cancer in Chinese patients.
Liang X; Li D; Geng W; Cao X; Xiao C
Tumour Biol; 2013 Apr; 34(2):995-1004. PubMed ID: 23296702
[TBL] [Abstract][Full Text] [Related]
7. Breast-Conserving Surgery in Bilateral Breast Cancer.
O'Brien JA; Ho A; Wright GP; Stempel M; Patil S; Krause K; Morrow M; Gemignani ML
Ann Surg Oncol; 2015 Oct; 22(10):3389-96. PubMed ID: 26265365
[TBL] [Abstract][Full Text] [Related]
8. Synchronous and metachronous bilateral breast cancer: clinicopathologic characteristics and prognostic outcomes.
Mruthyunjayappa S; Zhang K; Zhang L; Eltoum IA; Siegal GP; Wei S
Hum Pathol; 2019 Oct; 92():1-9. PubMed ID: 31351153
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of synchronous and metachronous bilateral breast cancer.
Kollias J; Ellis IO; Elston CW; Blamey RW
World J Surg; 2001 Sep; 25(9):1117-24. PubMed ID: 11571945
[TBL] [Abstract][Full Text] [Related]
10. The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours.
Carmichael AR; Bendall S; Lockerbie L; Prescott R; Bates T
Eur J Surg Oncol; 2002 Jun; 28(4):388-91. PubMed ID: 12099647
[TBL] [Abstract][Full Text] [Related]
11. Impact of bilateral breast cancer on prognosis: synchronous versus metachronous tumors.
Ibrahim NY; Sroor MY; Darwish DO
Asian Pac J Cancer Prev; 2015; 16(3):1007-10. PubMed ID: 25735321
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer.
Sandberg ME; Hartman M; Klevebring D; Eloranta S; Ploner A; Hall P; Czene K
Breast Cancer Res Treat; 2012 Jul; 134(2):793-800. PubMed ID: 22622811
[TBL] [Abstract][Full Text] [Related]
13. [Bilateral breast carcinoma. 12 years' experience].
Maculotti L; Gandini F; Pradella P
Minerva Chir; 1996; 51(1-2):33-7. PubMed ID: 8677043
[TBL] [Abstract][Full Text] [Related]
14. [Basal and myoepithelial phenotype of metastatic mammary carcinomas. A prognostic factor in the palliative situation?].
Mainka P; Kahlert S; Kirchner T; Mayr D; Diebold J
Pathologe; 2008 Nov; 29 Suppl 2():363-9. PubMed ID: 18807040
[TBL] [Abstract][Full Text] [Related]
15. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
16. Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours.
Sim Y; Tan VKM; Sidek NAB; Chia DKA; Tan BKT; Madhukumar P; Yong WS; Wong CY; Ong KW
ANZ J Surg; 2018 Oct; 88(10):982-987. PubMed ID: 30141242
[TBL] [Abstract][Full Text] [Related]
17. Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer.
Karsten M; Stempel M; Radosa J; Patil S; King TA
Ann Surg Oncol; 2016 Feb; 23(2):471-6. PubMed ID: 26340863
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features in bilateral breast cancer.
Baykara M; Ozturk SC; Buyukberber S; Helvaci K; Ozdemir N; Alkis N; Berk V; Koca D; Coskun U; Oksuzoglu B; Uncu D; Arpaci E; Ustaalioglu BO; Demirci U; Kucukoner M; Dogu GG; Alici S; Akman T; Ozkan M; Aslan UY; Durnali AG; Benekli M
Asian Pac J Cancer Prev; 2012; 13(9):4571-5. PubMed ID: 23167382
[TBL] [Abstract][Full Text] [Related]
19. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.
Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349
[TBL] [Abstract][Full Text] [Related]
20. Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer.
Tutzauer J; Sjöström M; Bendahl PO; Rydén L; Fernö M; Leeb-Lundberg LMF; Alkner S
PLoS One; 2020; 15(4):e0231786. PubMed ID: 32302351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
